搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Zacks.com on MSN
2 天
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics
Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow ...
Verywell Health on MSN
1 天
Hormone Therapy for Menopause Linked to Slower Biological Aging, Study Shows
A new observational study linked hormone therapy to slower biological aging in women who started the treatment after age 55 ...
Neurology Advisor
1 天
Biological Age vs Chronological Age Younger in Hormone Therapy Users
Biological age vs chronological age was younger among postmenopausal female individuals who received hormone replacement therapy.
1 天
Does Adjuvant Therapy Prevent Cancer Recurrence?
Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...
Medscape
11 天
Physicians Urged to Monitor Asthma Patients on Biologics for Remission and Potential EGPA ...
Physicians should track clinical remission in patients with asthma on biologics and monitor for EGPA symptoms, as ...
drugdeliverybusiness
3 天
BD launches new prefillable syringe, expands platform capacity
BD announced today that it launched its Neopak XtraFlow glass prefillable syringe and expanded the capacity for the platform.
PharmiWeb
12 天
Biologics CDMO Market
IntroductionIn recent years, the biologics market has witnessed exponential growth, driven by the increasing demand for ...
Managed Healthcare Executive
8 天
Patient Experience With Intravenous and Subcutaneous Therapies
An expert gastroenterologist dissects a study that analyzed patient experience with intravenous and subcutaneous biological therapies.
Everyday Health
1 天
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval
Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The medication is for adults and children 12 and older. In studies, people saw ...
2 天
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
The Phase III trial compared the efficacy of Fasenra with the standard treatment of GSK’s Nucala in patients with ...
Psychology Today
1 天
The 3 Pillars of Stress Reduction
Attending to our biological needs makes us mentally and physically prepared for stress reduction. The stories we tell ...
香港電台網站
11 天
'More subsidies needed for young children with eczema'
Eczema concern groups on Tuesday called on the government to subsidise young children to receive biological therapy to help ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈